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Mechanisms and consequences 
of ATMIN repression in hypoxic 
conditions: roles for p53 and HIF-1
Katarzyna B. Leszczynska1, Eva-Leonne Göttgens1, Deborah Biasoli1, Monica M. Olcina2, 
Jonathan Ient1, Selvakumar Anbalagan1, Stephan Bernhardt1, Amato J. Giaccia2 & 
Ester M. Hammond1
Hypoxia-induced replication stress is one of the most physiologically relevant signals known to activate 
ATM in tumors. Recently, the ATM interactor (ATMIN) was identified as critical for replication stress-
induced activation of ATM in response to aphidicolin and hydroxyurea. This suggests an essential role 
for ATMIN in ATM regulation during hypoxia, which induces replication stress. However, ATMIN also has 
a role in base excision repair, a process that has been demonstrated to be repressed and less efficient in 
hypoxic conditions. Here, we demonstrate that ATMIN is dispensable for ATM activation in hypoxia and 
in contrast to ATM, does not affect cell survival and radiosensitivity in hypoxia. Instead, we show that in 
hypoxic conditions ATMIN expression is repressed. Repression of ATMIN in hypoxia is mediated by both 
p53 and HIF-1α in an oxygen dependent manner. The biological consequence of ATMIN repression in 
hypoxia is decreased expression of the target gene, DYNLL1. An expression signature associated with 
p53 activity was negatively correlated with DYNLL1 expression in patient samples further supporting 
the p53 dependent repression of DYNLL1. Together, these data demonstrate multiple mechanisms of 
ATMIN repression in hypoxia with consequences including impaired BER and down regulation of the 
ATMIN transcriptional target, DYNLL1.
Hypoxia (insufficient oxygen levels) occurs in the majority of solid tumors due to aberrant and inefficient vas-
culature and is a negative prognostic factor for patients, irrespective of treatment modality1,2. The poor clinical 
outcome linked to highly hypoxic tumors is due to increased aggressiveness and metastatic potential, as well as 
chemo- and radiotherapy-resistance3,4. Hypoxia also potentiates genomic instability in tumors through down 
regulation of the DNA repair pathways, including base excision repair (BER), homologous recombination (HR) 
and mismatch repair (MMR)5–9. DNA repair has been shown to be repressed over a range of oxygen conditions 
which occur in human tumors10. The mechanisms of repression of repair are numerous (recently reviewed in11) 
and in some cases have been shown to be dependent on the hypoxia inducible factor (HIF-1)12. In contrast, 
hypoxia induced ATM activation is restricted to severely hypoxic conditions (< 0.1% O2), which also induce rep-
lication stress13,14. Hypoxia-induced ATM activation occurs in response to replication stress and in the context of 
specific chromatin modifications and importantly, in the absence of detectable DNA damage15–18. ATM activation 
in hypoxia occurs independently of the MRN complex, however, the requirement for alternative specific ATM 
interacting proteins has not been investigated13. As a result of ATM/ATR signaling in hypoxia the p53 tumor 
suppressor gene is activated and can lead to hypoxia-induced apoptosis19.
Recently, the ATM interacting protein (ATMIN, also known as ASCIZ) was described as having a role in 
the activation of ATM both in the absence of DNA damage (for example in response to NaCl and chloroquine 
induced hypotonic stress) and in response to replication stress induced by hydroxyurea (Hu) or aphidicolin 
(APH)20–25. These reports concluded that ATMIN is crucial for ATM activation in the absence of DNA damage, 
while NBS1 takes over this role when double DNA strand breaks are present e.g. in response to ionizing radiation 
(IR)21,23,24. It has also been suggested that ATMIN is important for the repair of DNA damage induced by agents 
such as methyl methanesulfonate (MMS) or H2O2, and is therefore likely to be involved in the BER pathway26. 
Specifically, ATMIN was demonstrated to be necessary for the formation of Rad51 foci in response to MMS 
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treatment, and for recruitment of 53BP1 to foci after both MMS and APH treatment22,26–29. A role for ATMIN in 
maintaining genomic stability was also demonstrated to be important in the suppression of B cell lymphoma30. 
Finally, ATMIN, which includes a Zn2+ finger domain, has been shown to act as a transcription factor driving 
expression of a very limited number of target genes including DYNLL1, which plays an important role in lung 
morphogenesis28,29.
Here, we demonstrate that ATMIN was not required for ATM activation in hypoxia and was instead repressed 
in hypoxic conditions therefore contributing to the hypoxia-mediated repression of DNA repair. The mecha-
nism of repression is complex and is in part dependent on both HIF-1 and p53, demonstrating that repression 
of ATMIN is critical to the biological response to hypoxia. While this may be due to the role of ATMIN in DNA 
repair, we also demonstrate for the first time that expression of the ATMIN target gene DYNLL1 is altered in 
response to hypoxia.
Results
ATMIN is dispensable for ATM activation in hypoxia. To test the hypothesis that ATMIN might be 
required for hypoxia-induced ATM activation, we used ATMIN siRNA to deplete ATMIN levels in RKO cells. 
The cells were then exposed to hypoxia (< 0.1% O2) for 3 h, as we have shown previously that ATM is activated 
during this period13. As expected, a robust induction of phosphorylated ATM (ATM-S1981) and the ATM target 
Kap-1 (Kap1-S824) was observed in response to hypoxia in the cells treated with the control siRNA. Surprisingly, 
a similar induction of ATM activity was also observed in the cells with depleted levels of ATMIN (Fig. 1A). To 
ensure that ATMIN did not have role in sustaining hypoxia-induced ATM activation, experiments over a longer 
time period were also carried out and again no dependence on ATMIN was observed (Figure S1). This finding 
Figure 1. ATMIN loss does not impair ATM activation in hypoxia. (A) RKO cells were transfected with 
either non-targeting scrambled siRNA or ATMIN-specific siRNA. 24 h post transfection, cells were exposed for 
up to 3 h of hypoxia (< 0.1% O2). (B) Colony survival assay of RKO cells treated with 10 μ M KU-55933, exposed 
to 6 h hypoxia (< 0.1% O2), and irradiated with 0–6 Gy. Post treatment, cells were allowed to form colonies 
for 8 days under normal tissue culture conditions. Mean and standard deviation (SD) from 3 independent 
experiments is shown. (C) RKO cells transfected with either scrambled (Scr) siRNA or ATMIN siRNA were 
exposed to 6 h of hypoxia treatment (< 0.1% O2) or left at normoxia (21% O2), followed by irradiation (4 Gy). 
Post radiation, cells were reoxygenated and kept under normal tissue culture condition to allow colony 
formation. (D) Colony survival assay of RKO cells transfected with ATMIN siRNA, exposed for up to 36 h 
of hypoxia (< 0.1% O2). For all colony formation data mean surviving fractions are shown ± SD from three 
independent experiments.
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was also verified with two single siRNAs to ATMIN (Figure S2). As a control, we verified that loss of ATMIN 
decreased ATM activity in response to APH-induced replication stress (Figure S3)22,31. Loss of ATM has a dra-
matic and well-characterized effect on radiosensitivity, although this has not been as extensively demonstrated 
under hypoxic conditions32. Here, we used an ATM inhibitor (KU-55933) in hypoxic conditions and exposed 
RKO cells to radiation (0–6 Gy). As expected, the cells treated with the ATM inhibitor were significantly more 
sensitive to radiation even in hypoxic conditions (SER37 = 2.1) (Figs 1B and S4). We then asked if ATMIN might 
contribute to the role of ATM in radiation response under hypoxic conditions by carrying out the same experi-
ment in cells treated with a siRNA against ATMIN. Loss of ATMIN did not affect the radiation sensitivity of cells 
irradiated under hypoxic conditions suggesting that ATM function could not have been significantly impacted by 
ATMIN depletion (Fig. 1C). Previous studies have shown that loss of ATM activity leads to increased sensitivity 
to hypoxia/reoxygenation15,33. Therefore, if ATMIN contributes to ATM activity in hypoxia, loss of ATMIN would 
also be expected to increase sensitivity to hypoxia/reoxygenation. Again, ATMIN was depleted using siRNA in 
RKO cells and a colony survival assay in response to hypoxia/reoxygenation was carried out. Depletion of ATMIN 
had no significant effect on cell viability in response to hypoxia compared to wild type RKO cells, which again 
suggests that ATMIN does not contribute to ATM activity during hypoxia (Fig. 1D). To further support this con-
clusion, we investigated the induction of apoptosis 6 hours after hypoxic exposure and found that loss of ATMIN 
did not significantly affect the fraction of apoptotic cells (Figure S5). Altogether, these data demonstrate that 
ATMIN is not required for the activation of ATM in response to hypoxia-induced replication stress.
ATMIN is repressed in an oxygen dependent manner through p53 and HIF-1α. While investigat-
ing the potential role of ATMIN on ATM activation in hypoxia we noticed that ATMIN levels decreased over time 
in hypoxia (Figure S1). Both cancer (RKO, HCT116) and non-cancerous (RPE1-hTERT) cell lines were exposed 
to hypoxia (< 0.1% O2) for up to 24 h and analyzed for ATMIN expression by western blotting. In each case the 
levels of ATMIN protein were significantly decreased in hypoxia (Fig. 2A–C). Next, we tested the oxygen depend-
ency of ATMIN decrease by comparing exposure to severe (< 0.1% O2) and mild hypoxia (2% O2). The levels of 
ATMIN decreased at both oxygen tensions, although more profoundly at < 0.1% O2 (27% and 55% decrease at 
2% O2 and < 0.1% O2, respectively, when compared to ATMIN levels at 21% O2) (Fig. 2D). In addition, we inves-
tigated the effect of commonly used hypoxia mimetics, desferoxamine (DFO) and CoCl2, and found that DFO 
treatment partially repressed ATMIN (25% decrease), while CoCl2 had no effect on ATMIN protein (Fig. 2D). 
As the levels of ATMIN have not been reported to change in response to stress previously, we asked if this also 
occurred upon exposure to alternative sources of replication stress. RKO cells were exposed to Hu or APH for a 
period of 3–6 h and the levels of ATMIN protein determined. No apparent decrease in ATMIN was detected in 
response to either treatment suggesting that hypoxia has a unique effect on ATMIN levels (Fig. 2E). To rule out 
repression of ATMIN with slower kinetics compared to hypoxia, no decrease in ATMIN expression was observed 
when cells were treated with Hu and APH for up to 18 h (Figure S6). Together, this data demonstrate that ATMIN 
is repressed in response to a range of hypoxic conditions (< 0.1–2% O2) but this effect is more profound at the 
more severe level of hypoxia.
As HIF-1 has been demonstrated to play a role in the repression of other DNA repair proteins in hypoxia we 
investigated a potential role for HIF-1 in ATMIN repression11. However, as the repression of ATMIN was more 
significant in severe hypoxia compared to milder levels we also included p53 in our analysis, as p53 activity is 
also restricted to severely hypoxic conditions34. We used isogenic cell lines HCT116 p53+/+ and p53−/− or RKO 
HIF-1α +/+ and RKO HIF-1α −/− to initially investigate this hypothesis. We observed that ATMIN repression in 
hypoxia was partially reversed when either p53 or HIF-1α were deleted (Figure S7A,B). To investigate further 
the contribution of p53 and HIF-1 to ATMIN repression, we used siRNA to knock down HIF-1α in a p53 null 
background and compared ATMIN protein levels after hypoxia. We observed that the combined depletion of p53 
and HIF-1α had the largest effect on rescuing ATMIN protein levels when compared to knock-down or deletion 
of either transcription factor alone (Fig. 2F). These results suggest that both p53 and HIF-1α independently con-
tribute to repression of ATMIN in hypoxia.
Hypoxia represses ATMIN expression at the protein level without increasing degradation 
rates. As both transcription factors HIF-1 and p53 play a role in ATMIN repression we investigated ATMIN 
mRNA expression in hypoxia. ATMIN mRNA was measured by qPCR in response to hypoxia in 5 cells lines 
(RKOp53wt, HCT116p53wt, U87p53wt, MCF-7p53wt and U2OSp53wt) all of which have a normal HIF-1 response. 
ATMIN mRNA levels were not significantly affected by hypoxia in the majority of the cell lines tested with the 
exception of HCT116 cells where mRNA decreased initially (after 8 h) and then basal levels were restored. These 
results demonstrate that in the cell lines tested, neither p53 nor HIF-1 directly or indirectly repress ATMIN 
transcription (Figs 3A–C and S8A,B). This was further confirmed by analyzing ATMIN mRNA expression in 
cells lacking either p53 (HCT116 p53−/−) or HIF-1α (RKO HIF-1α −/−), again no hypoxia-dependent increase in 
expression was observed (Figure S8C,D).
ATMIN contains a C-terminal PEST domain, which is associated with proteasomal degradation21. Given the 
stability of ATMIN mRNA in hypoxia we hypothesized that ATMIN could be repressed through increased protein 
degradation in hypoxia. We measured ATMIN in cells exposed to a proteasomal inhibitor (MG-132) either in nor-
moxia or in hypoxia. The hypoxia-mediated repression of ATMIN was abrogated by the addition of proteasomal 
inhibitor MG-132 confirming that ATMIN levels are regulated by proteasomal degradation (Fig. 3D). However, 
ATMIN also accumulated in normoxic conditions (21% O2) in the presence of MG-132, suggesting that ATMIN is 
not specifically targeted to the proteasome in hypoxic conditions. To verify this further we measured the half-life 
of ATMIN in both normoxia and hypoxia by blocking protein translation with cycloheximide. We determined 
that the half-life of ATMIN (approximately 4 hours) was not altered by exposure to hypoxia (Figs 3E and S9). 
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Together, these findings suggest that in response to hypoxia ATMIN translation is repressed as opposed to altered 
transcription or degradation rates.
Biological consequences of hypoxia-mediated repression of ATMIN include the down regula-
tion of ATMIN target DYNLL1. ATMIN has been described as having a role in BER although this role 
is somewhat unclear26,27. BER is known to be functionally repressed in hypoxic conditions and consequently 
hypoxic cells are less able to repair damage induced by agents such as MMS5. To determine if the loss of ATMIN 
expression contributes to the increased sensitivity to MMS observed in hypoxic cells we exposed cells treated with 
ATMIN siRNA to range of hypoxic conditions and MMS and carried out a colony survival assay. In agreement 
with previous reports we observed an increased sensitivity of hypoxic cells to MMS5. We also found a significant 
decrease in cell survival of cells treated with MMS when ATMIN levels were depleted (Fig. 4A)22,26,27. This effect 
was decreased in cells exposed to 2% O2 and completely abolished in cells treated with < 0.1% O2 (Fig. 4A), where 
ATMIN was most repressed as a result of the hypoxia exposure.
ATMIN directly transactivates DYNLL1, therefore suggesting the novel hypothesis that DYNLL1 mRNA levels 
might be regulated in an oxygen dependent manner29. In agreement with previous reports, we confirmed that 
DYNLL1 expression is dependent on ATMIN levels in RKO cells (Fig. 4B). Next, we exposed cells to hypoxia, and 
observed an oxygen-dependent down-regulation of DYNLL1 expression, again with a more profound decrease at 
< 0.1% O2 (Fig. 4C), which correlates with ATMIN levels (Fig. 2D). The hypoxia-mediated decrease in DYNLL1 
expression was rescued by over-expression of ATMIN in these conditions (Figs 4D and S10). As the decrease of 
Figure 2. ATMIN expression in hypoxia decreases in an oxygen dependent manner through HIF-1α and 
p53-dependent pathways. (A–C) RKO (A), HCT116 (B) and RPE1-hTERT (C) cells were exposed to hypoxia 
(< 0.1% O2) for the times indicated and western blot analysis was carried out using the antibodies indicated 
(β -actin was used as a loading control). (D) RKO cells were treated as indicated for a period of 16 h. The hypoxia 
mimetic drugs were used as follows; 100 μ M DFO and 150 μ M CoCl2. Western blots using the antibodies 
indicated are shown. (E) RKO cells were exposed to DMSO, 1 mM Hu or 5 μ g/ml APH for the indicated 
amount of time and western blot analysis was carried out for ATMIN, RPA 32 and β -actin (loading control). 
(F) HCT116 p53−/− cells were transfected with either HIF-1α siRNA or Scr siRNA and HCT116 p53+/+ cells 
were transfected with Scr siRNA. Cells were exposed to hypoxia (< 0.1% O2) for the times indicated and protein 
lysates analyzed by western blotting with the antibodies shown.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:21698 | DOI: 10.1038/srep21698
ATMIN in severe hypoxia was p53 dependent (Figs 2F and S7A), we asked if DYNLL1 was also regulated in a 
p53-dependent manner in hypoxia. Therefore we tested the levels of DYNLL1 mRNA in RKO cells treated with 
p53 siRNA. As predicted, hypoxia-mediated repression of DYNLL1 was partially but significantly rescued in the 
absence of p53 (Fig. 4E). This study highlights an entirely novel link between ATMIN regulation of DYNLL1 and 
tumor hypoxia.
To date no validated hypoxia signatures, which are specific to the levels of hypoxia which induce replication 
stress i.e. < 0.1% O2 exist. However, we recently identified a group of six genes, which are induced by p53 in 
response to hypoxia (< 0.1% O2) and can predict p53 status in vivo in multiple cancer types19. Therefore, we 
used this group of genes to investigate a potential correlation between DYNLL1 expression and hypoxic p53 
signaling in patient samples. Through analysis of the TCGA breast and lung cancer patient cohorts we found that 
DYNLL1 expression significantly and inversely correlated with the hypoxia-inducible p53-dependent group of 
genes (Pearson r = − 0.09197, p = 0.0013 for breast and Pearson r = − 0.2618, p < 0001 for lung cancers, respec-
tively) (Fig. 4E), suggesting that hypoxia- and p53-dependent repression of the ATMIN target DYNLL1 occurs in 
human cancers. Altogether, our data shows that repression of ATMIN in hypoxia is likely to have multiple con-
sequences, including contributing to the repression of DNA repair pathways and down regulation of the ATMIN 
target, DYNLL1.
Discussion
Despite having a role in ATM activation in response to replication stress, ATMIN does not play a role in 
hypoxia-induced ATM activation. Instead, we show for the first time that ATMIN is repressed in response to 
hypoxia and most significantly under severe hypoxia (< 0.1% O2). Our data demonstrates that ATMIN repression 
is in part dependent on both p53 and HIF-1α . The involvement of both transcription factors suggests that ATMIN 
Figure 3. Hypoxia represses ATMIN without increasing degradation (A–C) RKO (A), HCT116 (B) and 
U-87 (C) cells were exposed to hypoxia (< 0.1% O2) for the times indicated and ATMIN mRNA expression 
was analyzed by qPCR in relation to 18S (reference gene). The mean mRNA expression ± SD from three 
independent experiments is shown. (D) RKO cells were treated with DMSO or 5 μ M MG-132 under normoxic 
(21% O2) or hypoxic (< 0.1% O2) conditions for the times indicated and ATMIN levels were analyzed by 
western blotting. (E) RKO cells were treated with 25 μ g/mL cycloheximide under normoxic (21% O2) or hypoxic 
(< 0.1% O2) conditions for the times indicated. ATMIN protein expression was measured by western blotting 
and quantified in relation to β -actin levels. The mean ATMIN protein expression ± SD from three independent 
experiments is shown.
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would be repressed in a broad range of hypoxic conditions and therefore in large areas of tumor. Repression of 
ATMIN in hypoxia is suggested to contribute to down regulation of BER and decreased expression of DYNLL1, 
as summarized in the proposed model (Fig. 5). Importantly, we show that repression of DYNLL1 can be inversely 
Figure 4. Loss of ATMIN contributes to the hypoxia-mediated repression of DNA repair and a decrease in 
DYNLL1 expression. (A) RKO cells transfected with either Scr siRNA or ATMIN siRNA were exposed to 20 h 
of varying oxygen concentrations (21%, 2% and < 0.1% O2) followed by 1 h of MMS treatment (0.1–0.5 mM as 
indicated) at the same oxygen tension. Cells were then reoxygenated and the media replaced. Colonies were 
allowed to form at 21% O2 over a period of 8–10 days. Mean surviving fractions are shown ± SD from three 
independent experiments. (B) RKO cells were transfected with either Scr or ATMIN siRNA and expression of 
ATMIN and DYNLL1 mRNA was analyzed by qPCR at 48 h post transfection. (C) DYNLL1 mRNA expression 
was analyzed by qPCR in RKO cells exposed to 16 h of varying oxygen concentrations (21%, 2% and < 0.1% O2). 
(D) RKO cells were transfected with pMSCV-ATMIN vector or an empty vector control. 24 h later cells were 
transferred to hypoxic conditions (< 0.1% O2) for 8 h. qPCR was then carried out for DYNLL1. (E) DYNLL1 
mRNA was analyzed by qPCR in RKO cells transfected with either Scr or p53 siRNA and exposed to 16 h 
of hypoxia (< 0.1% O2). All qPCR bar graphs show mean mRNA expression ± SD from three independent 
experiments. (F,G) Expression of DYNLL1 (Log10 conversion) in the breast (E) and lung (F) TCGA datasets is 
shown against hypoxia-inducible p53 signature (Log10 conversion). One-tailed p value is shown on each graph 
for each Pearson r (correlation coefficient).
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correlated with p53 signaling in human cancers suggesting that the consequences of ATMIN repression are likely 
to play a role in tumors in vivo.
The mechanism of repression of ATMIN protein in hypoxia remains unclear, although dependence on 
p53 and HIF-1α in this process may suggest involvement of micro-RNAs (miRs). Both p53 and HIF-1α are 
known to induce expression of multiple miRs, which are likely to inhibit protein translation35,36. Analysis of the 
ATMIN mRNA sequence using available online resources (e.g. www.microrna.org) showed that multiple p53 
or HIF-dependent miRs are predicted to bind to the ATMIN transcript, including miR-373 (a HIF-1α target) 
and miR-34 (a p53 target)12,37,38. In addition, a recent study, which screened for the miR-124 targets involved 
in the DNA damage response, found ATMIN to be regulated by miR-12439. Importantly, miR-124 is a known 
direct target of p53 suggesting that it is likely to be involved in down-regulation of ATMIN under hypoxia40. It 
is noteworthy that the dependence on p53 and HIF-1 for repression of ATMIN in hypoxia was less significant 
after longer exposure times to hypoxia (> 16 h). This finding suggests that in chronic hypoxic conditions ATMIN 
might be repressed through an alternative mechanism. A recent study characterized the repression of the BER 
pathway in chronic hypoxia (72 h 0.2% O2) as a consequence of inhibited protein translation5. Together, these 
findings suggest that the repression of ATMIN occurs in hypoxia through mechanisms dependent on HIF-1, p53 
and eventual decrease in translation.
Finally, we show that ATMIN repression in hypoxia is linked with down regulation of DYNLL1 expression. 
Numerous functions have been attributed to DYNLL1, including regulation of mitosis, spindle orientation, mac-
ropinocytosis, nuclear localization/translocation of some proteins e.g. 53BP1, PAK1 or ciliogenesis41–44. Our 
findings suggest that some or all of these processes will be altered in response to hypoxia through the decreased 
expression of DYNLL1. In support of this conclusion we have shown that 53BP1 does not form foci in response to 
hypoxia (< 0.1% O2) and so there would be no requirement for this function of DYNNL113. Most importantly our 
data demonstrate that in the absence of functional p53 the hypoxia-mediated repression DYNNL1 described here 
is alleviated. The specific roles of DYNNL1 in hypoxia driven tumor progression therefore warrant further study.
Methods
Cell lines, transfections and drug treatments. RKO, HCT116 (colorectal carcinoma cells), RPE1-
hTERT (retinal epithelial cells), HCT116 p53+/+ and p53−/− cell lines (Prof Vogelstein, Johns Hopkins45), RKO 
HIF-1α +/+ and HIF-1α −/− 46 were cultured in DMEM with 10% FBS. For siRNA knockdown, cells were trans-
fected using Dharma-FECT 1 reagent (Thermo Fisher Scientific) at 50 nM siRNA and used in assays from 24 
to 72 h after transfection. Human ATMIN ON-Target SMARTplus siRNA targeting sequences used as a pool 
or separately: si#1 5′-UUUGAAACAGGACCGAAA-3′; si#2 5′-UUACAACACCACCGAGAUA-3′; si#3 
5′-GAUAGAAAGUCCAACGGAU-3′; si#4 5′-CCGAACUGGGCACGAGAUA-3′; were from GE Healthcare 
Dharmacon (L-020304-01-0005). pMSCV-ATMIN vector was a kind gift from Prof Axel Behrens (The Francis 
Crick Institute, London) and was transfected using Lipofectamine Ltx reagent (Life Technologies)24. Drugs were 
purchased from Sigma unless otherwise stated and were used at the following concentrations: 100 μ M DFO, 
150 μ M CoCl2, 1 mM Hu, 1 μ M APH, 25 μ g/ml cycloheximide, 5 μ M MG-132 or 10 μ M KU-55933 (Tocris).
Colony survival. RKO cells were transfected with 50 nM ATMIN siRNA and the next day re-plated at a 
density of 250–2000 cells/well in a 6-well plate. After 2 h, cells were exposed to < 0.1% O2 for 0–36 h and/or drug 
treatment and then left for 7–9 days to form colonies, which were visualized by crystal violet staining.
Hypoxia and radiation. Hypoxic treatments at < 0.1% O2 were carried out in a Bactron chamber (Shel Lab) 
and at 2% O2 in a Don Whitley H35 Hypoxystation. Radiation doses were delivered in a GSM D1 137-Cesium 
gamma irradiator with at 0–6 Gy doses as previously described47.
Western blotting. Protein lysates were extracted with SDS lysis buffer (10 mM Tris-Cl, pH 7.5, 0.1 mM 
EDTA, 0.1 mM EGTA, 0.5% SDS, 0.1 mM β -mercaptoethanol, protease/phosphatase inhibitors) and western 
blotting carried out as described previously34. Western blots were imaged using the Odyssey infrared system 
(LI-COR). The following antibodies were used: ATMIN (Millipore), HIF-1α (BD Biosciences), p53 (Santa Cruz), 
Figure 5. ATMIN expression is repressed in response to hypoxia through mechanisms which include 
both HIF-1a and p53. The involvement of both HIF-1α and p53 in the repression of ATMIN suggests that this 
would occur in a significant fraction of the tumour, although p53-mediated repression was more robust. The 
consequences of loss of ATMIN include increased sensitivity to DNA damaging agents requiring effective BER 
for repair and decreased expression of DYNLL1. Some of the potential consequences of loss of DYNNL1 in 
hypoxia are indicated and warrant further study.
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β -actin (Santa Cruz), ATM (Sigma and Cell Signaling), pATM-S1981 (Epitomics), Kap1-S824 (Bethyl), Kap1 
(Bethyl), γ H2AX (Millipore) and H2AX (Calbiochem).
RT-qPCR. Cells were lysed in TRI reagent (Sigma) and mRNA extracted according to manufacturer instruc-
tions. The RNA was quantified using NanoDrop. cDNA was synthesized using 500 ng RNA and the Verso cDNA 
Enzyme kit (Life Technologies). qPCR was carried out with SYBR mix using a 7500 Fast Real-time PCR Detection 
System (Applied Biosystems). Primer sequences: ATMIN forward: 5′-AACAGCACTGCAGTCTCACA-3′; 
ATMIN reverse: 5′-CTGGTCTAGGGATTGGTTGGT; 18S forward: 5′-GCCCGAAGCGTTTACTTTGA-3′; 18S 
reverse: 5′-TCCATTATTCCTAGCTGCGGTATC-3′; DYNLL1 forward: 5′-AGATGCAACAGGACTCGGTG-3′; 
DYNLL1 reverse: 5′-CCACTTGGCCCAGGTAGAAG-3′.
Expression analysis in cancer datasets. Raw RNA-sequencing (RNA-seq) data for 1105 Breast invasive 
carcinoma and 522 Lung adenocarcinoma tumors were downloaded from the TCGA project (accessed through 
cBioportal: http://www.cbioportal.org/) on 10th September 2015 and 12th September 2015 respectively. To exam-
ine tumor-associated p53-activity (referred to as p53 signature in the figure), raw data for each sequenced gene 
were rescaled to set the median equal to 1, and p53-activity was quantified by averaging the normalized expres-
sion of 6 p53 target genes, associated with hypoxia-induced p53 activity (encoding BTG2, CYFIP2, INPP5D, 
KANK3, PHLDA3 and SULF2)19. Log10 conversion of the p53 signature was plotted against Log10 conversion of 
raw data for DYNLL1 (also rescaled to set the median equal to 1). One-tailed p value shown on each graph for 
each Pearson r (correlation coefficient).
Statistical analysis. Statistical analysis of clonogenic assays, mRNA expression and expression analysis in 
cancer datasets was carried out using Graphpad Prism v6.03 software. For colony survival assays the plating 
efficiency per condition was determined by dividing the total number of counted colonies by the total number 
of plated cells. Surviving fractions (SF) were calculated by dividing the plating efficiency of treated cells by the 
plating efficiency of the control cells. Comparison of groups was done using an unpaired t-test with Welch’s 
correction. Data was fitted according to the linear quadratic model using the formula SF = e^ − (α D + β D2). 
Sensitizer enhancement ratio (SER) was calculated as SER37 = D0(without sensitizer)/D0(with sensitizer) for the 
same biological effect at SF = 37%. qPCR data was analyzed on 7500 Software V.2.0.5 (Applied Biosystems) using 
the Δ Δ Ct method. An unpaired t-test with Welch’s correction was used. Statistical significance is marked as 
follows: *p < 0.05, **p < 0.01, ***p < 0.001.
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